Valitor
Latest round
- Series B
Last raised
- Dec 2021
Total raised
- $17M
Investors
- 5
About Valitor
Valitor, Inc.Founded in 2010 in Berkeley, US, Valitor, Inc. specializes in creating advanced therapies for ophthalmological conditions.Valitor, Inc. specializes in the development of innovative ophthalmic therapies, focusing primarily on addressing vision-threatening diseases through its proprietary Multivalent Polymer (MVP) technology platform. The company's lead product, VLTR-559, is an advanced, long-acting treatment for wet age-related macular degeneration (AMD), designed to improve patient outcomes by offering a twice-yearly dosing regimen. Valitor's MVP technology is engineered to enhance bioactive molecules' therapeutic durability, targeting ocular diseases while also addressing potential indications in oncology and joint diseases.Valitor's revenue model centers on partnerships with pharmaceutical companies and healthcare institutions focused on ophthalmology. The company engages in B2B transactions, collaborating with other firms to facilitate the development and commercialization of its therapies. Revenue is generated through strategic collaborations involving shared development costs, clinical advancement milestones, and royalties on product sales upon market entry.In December 2021, Valitor, Inc. The company aims to expand its product offerings, although specific upcoming products and release dates have not been disclosed.
Who invested in Valitor
5 investors across 2 rounds
See all investors in Valitor
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Valitor
Who invested in Valitor?
Valitor has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Valitor raised?
Valitor has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Valitor last raise money?
Valitor's most recent round on record is a Series B, in Dec 2021.
What does Valitor do?
Valitor is a biotechnology company.
Where is Valitor headquartered?
Valitor is headquartered in Berkeley, US.
Which VCs invest in companies like Valitor?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Valitor's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Valitor? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.